our science
Pipeline

SCROLL DOWN
Pipeline
Pipeline
Program Project Indication Target Discovery Pre-clinical Phase I Phase II Phase III
Hit to Lead Lead Optimization
Neuro
degeneration
AB-12 po Alzheimer’s disease Tau
AB-12 iv Alzheimer’s disease Tau
AB-14 Amyotrophic lateral
sclerosis (ALS)
TDP43
AB-19 Progressive
supranuclear
palsy (PSP)
Tau
AB-16 Parkinson’s disease α-synuclein
Amyloidosis AB-21 hATTR Transthyretin
Cancer AB-31 Lung Ras
AB-32 Prostate AR
AB-33 Pancreatic p53
Animal Drug AB-81 Dog dementia Tau